EventSpan

Speaker:

Steffen Mittwich

Speaker: Dr. Rob Lammens

Full description:

Can dry granulation be a full alternative to wet granulation and also help in developing difficult substances? Atacama Labs offers fast galenic development and full scale production services to pharmaceutical companies based on an innovative dry granulation technology called PDG (pneumatic dry granulation).  

The webinar will lead you through the technology, individual technological and commercial advantages as well as its application fields and show detailed results of a number of APIs developed with the technology.

The advantages and solutions provided are adapted to an audience of galenic developers, production heads and life cycle managers working in the field of Rx/OTC/Generic pharmaceuticals and include a stepwise business model for easy client access and testing.

Attendees to this webinar will understand how this innovative technology can:

• Effectively replace wet granulation with dry granulation with much lower costs and no scale-up issues
• Deliver both flowable and compactable granules
• Solve NCE development issues regarding drug loading, solubility, heat lability, hygrophilic / stability
• Provide effective solutions for ODT forms as well as fixcombinations

Intended audience: This is a must attend webinar for galenic developers, production heads and life cycle managers working in the field of Rx/OTC/Generic pharmaceuticals.

Technical requirements: - PC headset - PC speakers - Broadband Connection